NCT06607731View on ClinicalTrials.gov

Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy

RecruitingOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Bone Angioma
Interventions
OTHER

Collecting data from medical records

Data collected: clinical data (particularly pain), biological data, imaging.

Trial Locations (1)

42270

RECRUITING

CHU de Saint-Etienne, Saint-Priest-en-Jarez

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER